Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Akkaraju Srinivas
Relationship:  
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   22    
Direct Shares   3,989,025    

Indirect Shares

   55,092,896      
Direct Value   $19,654,200    

Indirect Value

   $732,533,282      
Total Shares   59,081,921      
Total Value   $752,187,481      


Seagen Inc $9,493,396 Paratek Pharmaceuticals Inc $2,635,786 Icagen Inc $0 MEI Pharma Inc $6,732,465 Aravive Inc $1,276 Syros Pharmaceuticals, Inc. $94 Scholar Rock Holding Corp $791,182 Seagen Inc $9,493,396 Paratek Pharmaceuticals Inc $2,635,786 Icagen Inc $0 MEI Pharma Inc $6,732,465 Aravive Inc $1,276 Syros Pharmaceuticals, Inc. $94 Scholar Rock Holding Corp $791,182
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    4   
    2    

     Stock price went up :
    0   
    0    
     Stock price went down :
    4   
    2    
   
     Gain/Loss Ratio :
   -4.0   
   -2.0   
     Percentage Gain/Loss :
   -28.1%
 -88.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Pharmos Corp PARS Director 0 2006-10-25 2,845,160    Premium*  
            Seagen Inc SGEN Director 2020-05-15 41,503 2008-09-22 600,559    Premium*  
            Paratek Pharmaceuticals Inc PRTK Former 10% Beneficial ... 2011-07-19 1,181,967 0    Premium*  
            World Heart Corp WHRT 10% Owner 2012-08-02 0 2010-01-26 0    Premium*  
            Icagen Inc ICGN 2011-07-28 200,500 0    Premium*  
            Synageva BioPharma Corp GEVA Former Director 0 2012-06-27 1,026,832    Premium*  
            Durata Therapeutics, Inc. DRTX 10% Owner 2012-07-24 0 2012-07-24 3,028,439    Premium*  
            MEI Pharma Inc MEIP 10% Owner 2013-02-19 2,502,775 0    Premium*  
            Zs Pharma, Inc. ZSPH Director 2015-12-17 0 2014-06-23 609,455    Premium*  
            aTyr Pharma Inc LIFE Former 10% Owner, Dire... 2015-05-12 0 2015-05-12 1,866,126    Premium*  
            Aravive Inc ARAV Director 2019-12-02 31,815 2019-12-02 576,066    Premium*  
            Syros Pharmaceuticals, Inc. SYRS 2024-09-16 9,333 2023-12-21 1,786,427    Premium*  
            Principia Biopharma Inc PRNB Director 2018-09-18 0 2018-09-18 383,480    Premium*  
            Chinook Therapeutics Inc KDNY Director 2023-08-11 0 2023-08-11 0    Premium*  
            Lenz Therapeutics LENZ 10% Owner 2021-06-29 0 2022-04-12 8,497,067    Premium*  
            Scholar Rock Holding Corp SRRK Director 2025-05-22 21,132 2025-05-22 5,612,896    Premium*  
            Cargo Therapeutics, Inc. CRGX 10% Owner 0 2024-05-30 4,415,689    Premium*  
            Mineralys Therapeutics, Inc. MLYS 2024-02-12 0 2025-03-13 5,674,916    Premium*  
            Vtv Therapeutics Inc. VTVT 2024-02-27 0 2024-03-05 206,784    Premium*  
            Alumis Inc. ALMS 2024-07-01 0 2025-05-21 4,801,370    Premium*  
            Neurogene NGNE 10% Owner 2024-11-26 0 2024-11-26 1,717,127    Premium*  
            Kalaris Therapeutics, Inc KLRS 2025-03-18 0 2025-03-18 11,444,503    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SRRK Scholar Rock Holding Corp Director   –       •      –    2025-05-22 4 A $0.00 $0 D/D 7,632 21,132 0 -
ALMS Alumis Inc.   –       •      –    2025-05-21 4 A $0.00 $0 I/I 1,214,582 4,801,370 0 -
ALMS Alumis Inc.   –       •      –    2025-05-05 4 B $4.58 $749,676 I/I 160,370 3,586,788 0.01 %
ALMS Alumis Inc.   –       •      –    2025-05-02 4 B $4.55 $727,636 I/I 159,920 3,426,418 0.01 %
KLRS Kalaris Therapeutics, Inc   –       •       •   2025-03-18 4 A $0.00 $0 I/I 11,444,503 11,444,503 0 -
MLYS Mineralys Therapeutics, I...   –       •      –    2025-03-13 4 B $13.50 $8,100,000 I/I 600,000 5,674,916 0.01 -
NGNE Neurogene 10% Owner   –       –       •   2024-11-26 4 B $24.91 $1,259,623 I/I 48,770 1,717,127 1.5 -
NGNE Neurogene 10% Owner   –       –       •   2024-11-25 3 IO $0.00 $0 I/I 0 1,668,357 -
SRRK Scholar Rock Holding Corp   –       •      –    2024-10-07 4 AS $27.50 $34,385,673 I/I (1,175,713) 5,612,896 0 %
SYRS Syros Pharmaceuticals, In...   –       •      –    2024-09-16 4 OE $0.00 $0 D/D 2,667 9,333 0 -
ALMS Alumis Inc.   –       •      –    2024-07-01 4/A B $16.00 $25,000,000 I/I 1,562,500 3,266,498 0.01 -
ALMS Alumis Inc.   –       •      –    2024-07-01 4 A $0.00 $0 I/I 1,703,998 1,703,998 0 -
ALMS Alumis Inc.   –       •      –    2024-07-01 4 D $0.00 $0 I/I (1,703,998) 0 0 -
SRRK Scholar Rock Holding Corp   –       •      –    2024-06-27 4 A $0.00 $0 D/D 13,500 13,500 0 -
SYRS Syros Pharmaceuticals, In...   –       •      –    2024-06-01 4 OE $0.00 $0 D/D 4,000 6,666 0 -
CRGX Cargo Therapeutics, Inc. 10% Owner   –       –       •   2024-05-30 4 B $17.00 $4,998,000 I/I 294,000 4,415,689 1.5 -
VTVT Vtv Therapeutics Inc.   –       •       •   2024-03-05 4 D $0.00 $0 I/I (58,836) 206,784 0 -
VTVT Vtv Therapeutics Inc.   –       •       •   2024-02-27 4 A $11.81 $2,654,085 I/I 224,732 265,620 0 -
VTVT Vtv Therapeutics Inc.   –       •       •   2024-02-23 3 IO $0.00 $0 I/I 0 40,888 -
MLYS Mineralys Therapeutics, I...   –       •       •   2024-02-12 4 A $13.50 $7,499,993 I/I 555,555 5,074,916 0 -
SYRS Syros Pharmaceuticals, In... Director   –       •      –    2023-12-21 4 B $4.42 $3,999,998 I/I 904,977 1,786,427 2.1 %
CRGX Cargo Therapeutics, Inc. 10% Owner   –       –       •   2023-11-14 4 A $0.00 $0 I/I 3,381,323 3,455,023 0 -
CRGX Cargo Therapeutics, Inc. 10% Owner   –       –       •   2023-11-14 4 B $15.00 $9,999,990 I/I 666,666 4,121,689 1.5 -
CRGX Cargo Therapeutics, Inc. 10% Owner   –       –       •   2023-11-09 3 IO $0.00 $0 I/I 0 73,700 -
SRRK Scholar Rock Holding Corp Director   –       •       •   2023-10-16 4 B $6.85 $15,000,000 I/I 2,189,781 6,788,609 2.25 %
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us